Kellerhals Carrard advises BVF Partners on its deal with NLS Pharmaceutics

As we have informed here NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announced that it has entered into a definitive agreement with funds managed by BVF Partners, a US fund manager, to raise aggregate gross proceeds of up to USD 30 million in a two-tranche private placement.

Kellerhals Carrard advised BVF on all Swiss legal aspects. The team consisted of partner Nicolas Mosimann (pictured), partner Marc Hanslin and Kevin MacCabe (all m&a/capital markets).

Kellerhals Carrard advises BVF Partners on its deal with NLS Pharmaceutics


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram